Yiran Gan 4/8/25 Yiran Gan 4/8/25 Cerebral white matter damage in patients with end-stage kidney disease associates with cognitive impairment Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 Parkinsonism in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy: Clinical Features and Biomarkers Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 Ultrasensitive Assays Detect Different Conformations of Plasma β Amyloids Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 Mediating role of obstructive sleep apnea in altering slow-wave activity and elevating Alzheimer’s disease risk: Pilot study from a northern Taiwan cohort Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 Association of Rapidly Elevated Plasma Tau Protein With Cognitive Decline in Patients With Amnestic Mild Cognitive Impairment and Alzheimer’s Disease Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 Changes in plasma biomarkers differentiate clinical stages of Alzheimer's disease using immunomagnetic reduction assays Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 Theoretical Explorations of Reductions in The Alternative-current Magnetic Susceptibility of Reagent in Immunomagnetic Reduction Assay Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 Biomarker Assessment in Parkinson’s Disease Dementia and Dementia with Lewy Bodies by the Immunomagnetic Reduction Assay and Clinical Measures Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 Longitudinal assessment of plasma biomarkers for early detection of cognitive changes in subjective cognitive decline Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 Differential neuropsychiatric associations of plasma biomarkers in older adults with major depression and subjective cognitive decline Read More Older Posts
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Cerebral white matter damage in patients with end-stage kidney disease associates with cognitive impairment Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Parkinsonism in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy: Clinical Features and Biomarkers Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Ultrasensitive Assays Detect Different Conformations of Plasma β Amyloids Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Mediating role of obstructive sleep apnea in altering slow-wave activity and elevating Alzheimer’s disease risk: Pilot study from a northern Taiwan cohort Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Association of Rapidly Elevated Plasma Tau Protein With Cognitive Decline in Patients With Amnestic Mild Cognitive Impairment and Alzheimer’s Disease Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Changes in plasma biomarkers differentiate clinical stages of Alzheimer's disease using immunomagnetic reduction assays Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Theoretical Explorations of Reductions in The Alternative-current Magnetic Susceptibility of Reagent in Immunomagnetic Reduction Assay Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Biomarker Assessment in Parkinson’s Disease Dementia and Dementia with Lewy Bodies by the Immunomagnetic Reduction Assay and Clinical Measures Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Longitudinal assessment of plasma biomarkers for early detection of cognitive changes in subjective cognitive decline Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Differential neuropsychiatric associations of plasma biomarkers in older adults with major depression and subjective cognitive decline Read More
